Page 359 - எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

120 volunteers for India safety study shots Trial nod for homegrown RNA vaccine The human safety test run in India will offer the candidate to 120 volunteers 60 in the 18-55 years age group, and 60 in the 56-75 years age group Two years ago, Sanjay Singh, a biochemist and chief executive officer of a Pune-based biotechnology company producing drugs for cancers and strokes, turned his attention to a new “platform” to design personalised vaccines against breast cancer. Singh, working with his long-term research collaborator in the US, Steve Reed, set out to design vaccines based on the genetic material called mRNA and tailored to stimulate patients’ immune systems into attacking their own breast tumour cells.

Govindrajan padmanabhanSteve reedSanjay singhKing edward memorial collegeIndian institute of scienceUs national institutes of healthGovernment medical collegeCentral drugs standard control organisationPune based gennova biopharmaceuticalsIndian instituteஸ்டீவ் நாணல்சஞ்சய் சிங்கிங் எட்வர்ட் நினைவகம் கல்லூரிஇந்தியன் நிறுவனம் ஆஃப் அறிவியல்எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம்அரசு மருத்துவ கல்லூரி